The Society of Thoracic Surgeons (STS) has released the first publicly accessible national report of surgical outcomes from its Congenital Heart Surgery Database (CHSD), a component of the STS National Database. Public reporting results are available at www.sts.org/publicreporting.

TAVR, TAVI, acc, ACC.15, corevalve

Key data from many transcatheter aortic valve replacement (TAVR) clinical trials will be presented as late-breakers at the American College of Cardiology (ACC) Scientific Session this weekend, March 14-16, 2015, in San Diego, Calif. While the three-day conference will be packed with lectures, poster presentations, case studies, etc., most investors will be waiting for TAVR-related clinical data from Edwards and Medtronic. We expect these data to be positive for both vendors, which will only help to solidify their hold on the global TAVR market.

The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell analysis showing that the growth of nuclear medicine in the future will come through therapeutic radiopharmaceuticals (radiotherapeutics). Revenue for Xofigo – a product used in the treatment of prostate and bone cancers – reached EUR 157 million (US$ 209 million) in 2014.

Researchers at the University of California, San Diego School of Medicine have identified a key piece in the complex molecular puzzle underlying heart failure.

Carroll Hospital Center physicians will now have 24/7 remote access to the University of Maryland Medical Center’s (UMMC) Brain Attack Team through a new telemedicine service for stroke patients.

George Adams, M.D., an interventional cardiologist with North Carolina Heart and Vascular, successfully treated a patient having an acute myocardial infarction (AMI) with the Aspire Mechanical Thrombectomy System.

In an analysis of outcomes of about 12,000 patients who underwent transcatheter aortic valve replacement (TAVR), death rate after one year was nearly one in four, according to a study in the March 10 issue of JAMA. Of those alive at 12 months, almost half had not been rehospitalized and approximately 25 percent had only one hospitalization.

Carestream is demonstrating its new Touch Ultrasound System at the American Institute of Ultrasound in Medicine (AIUM) annual meeting, March 21-25.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now